Biosimilar User Fee Rates for Fiscal Year 2027 | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2026-N-7707

Biosimilar User Fee Rates for Fiscal Year 2027

Documents

Comments

Description

OPEN

Comment Period OpensJul 30, 2026

Type	Title	Posted	Comments	Status
Notice	Biosimilar User Fee Rates for Fiscal Year 2027 FR Doc: 2026-15346	Jul 30, 2026	--

2026-241

Biosimilar User Fee Rates for Fiscal Year 2027

OPEN